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Atopic dermatitis is an inflammatory skin disease character-
ized by dryness and itch of the skin. In this study, we mea-
sured the phospholipid content and the fatty acid pattern of 
lesional and lesion-free epidermal keratome biopsies on 15 
patients. For comparison, epidermal biopsies were obtained 
from healthy individuals undergoing plastic surgery. The 
phospholipid content of atopic epidermis was nearly tw!ce as 
high as in healthy epidermis. Monounsaturated fatty ac1ds 111 
the phosphoglycerides were significantly increased (p < 
0.001) and n-6 fatty acids were significantly decreased (p < 
0.001) in lesional atopic epidermis compared to lesion-free 
epidermis. The content of esterified arachidonic acid in phos-
C omplex lipids and esse ntial fatty acids are vital for th e normal function of the skin. A group of complex lipids, the 0-acylceramides, are located intercellu-larly in multipl e bilayers parallel to the plane of the skin surface in the stratum corneum. They are essen-
tial com ponents of the epidermal water barrier and are unique to 
keratinizi ng epithelia [1] . The oth er lipids of the stratum corneum 
are cholesterol, free fatty acids, ceramides, and gangliosides [ 1]. 
Phospholipids are almost exclusively found in the lower basal and 
spinous cell membranes, w hereas they are normally absent from the 
stratum corn eum [1] . Phospholipids ca rry polyunsaturated fatty 
acids (PUFA), w hich are the precursors of eicosanoids. These are 
important mediators and regulators of skin inflammation [2]. Cardi-
nal features of atopic dermatitis (AD) are the dry, scaly dermatosis 
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Abbreviations: 
AD: atopic dermatitis 
BHT: butylated hydroxy toluene 
FAME: fatty acid methyl esters 
FFA: free fatty acids 
GC: gas chromatography 
HPLC: hi gh-pressure liquid chromatography 
LCSFA: long-chain saturated fatty acids (C22-C26) 
MUFA:monounsaturated fatty acids 
n-6: n-6 fa tty acids 
n-3: n-3 fatty acids 
PC: phosphatidylcholine 
PE: phosphatidy lethanol amine 
PUFA: polyunsaturated fatty acids 
SCSFA: short-chain saturated fatty acids (C14-C18) 
SFA: saturated fatty acids 
phatidylcholine from lesional epidermis w as only 49% of 
that found in healthy epidermis (p < 0.001) . The content of 
free arachidonic acid was 47% higher (p < 0.05), whereas 
the content of free long-chain saturated fatty acids was de-
creased by 29% (p < 0.01), in lesional compared to lesion-
free atopic epidermis. The disease severity, calculated as an 
arbitrary index, correlated inversely with th e n-6 fatty acid 
content of lesion-free atopic epidennis (r =- 0.89, p < 
0.001). Our findings suggest that atopic epidermis is charac-
terized by an increased activity of phospholipase A2 and an 
incomplete transformation of phospholipids into other lipid 
classes. J Invest D erma to/ 96:10-15, 1991 
and pruritus [3]. The biochemical abnormalities underlying these 
changes have not been identified. The skin manifestations in AD 
show simi lariti es with those of essential fatty acid-defi cient animals, 
where the function of the water permeability barrier is impaired due 
to linoleic acid deficiency [2] . The transepidermal water loss has, 
indeed, been shown to be increased in the skin of AD patients, and it 
has been suggested that they have a primary defect in the epidermal 
barrier located in the stratum corneum [4]. Recent investigations 
have also shown that arachidonic acid-derived inflammatory media-
tors occur at elevated levels in the lesional skin of AD patients (5,6]. 
The tissue concentration of eicosanoids depends on the avail ability 
of free arachidonic acid , which in turn depends on the activity of 
calcium-sensitive phospholipase A2 • This enzyme liberates PUFA 
from phosphoglycerides , primarily phosphatidylcholine (PC) [7]. 
The ac tivity of phospholipase A2 has been reported to be increased 
in another inflammatory skin disease, psoriasis [8] . 
The aim of the present study was to characterize the phosphogly-
ceride fatty acid composition and the free fatty acid (FFA) pattern in 
the epidermis of AD patients. This was compared to healthy epider-
mis. 
MATERIALS AND METHODS 
Subjects Fifteen adult patients with AD, eight premenopausal 
women and seven men attending the Department of Dermatology 
at Marselisborg Hospital, agreed to participate in the study. Their 
ages ranged from 19-51 , with the mea n age being 32 ± 10 years. In 
11 of the patients, eczema had commenced before the second year of 
life. In one patient, it started at 15, and in three, during adulthood. 
Five were smokers. None of the patients received topical or systemic 
treatment 2 weeks prior to the study. The affected body surface 
ranged from 3-70%. In 10 of the patients, it ranged from 10-5 0%. 
Four of the female patients used oral contraceptives . Exclusion cri-
teria were over- or underweight differing by more than 20% from 
the idea l weight, diabetes, and hyperlipidemia. In order to grade the 
condition of the patients, an arbitrary severity index was used and 
calcul ated in the following way: the total fraction of affected skin 
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was estimated. Redness, infiltration, scale, lichenification, and ex-
coriation of lesionalskin were each given a value from 0-3 for the 
face (including neck), arms (including hands) , body, and legs (m-
cluding feet) . The total score for each region w as multiplied by the 
fraction of body surface covered by that reg1on (0.1 0, 0.20, 0.36, 
and 0.34 for face, arms, body, and legs, respectively). The sum of 
these four numbers was multiplied by the total fraction of affected 
skin. On this scale, severity ranged from 0.09- 8.4. Itch and dryness 
of lesion-free skin were considered separately and also graded from 
0-3. 
Epidermal biopsies from lesional and lesion-free sites on the ex-
tremities, and a few from the trunk, were taken under local anaesthe-
sia with 1% lidocaine, with a keratome set at 0.2 mm. In this way, 
two-thirds of the epidermis was removed (9]. The biopsies (50 -
250 mg) were immediately placed in liquid nitrogen in order to 
minimize hydrolytic reactions. Normal skin was obtained from 
nine female patients without skin disease, aged 27 ± 10 years, un-
dergoing plastic surgery of the breast. Epidermal s.lices were s~aved 
off with the same keratome set at 0.2 mm after exc1s1on of the tissue. 
Hereafter, the sample was frozen at -7o•c until analysis, which 
cook place within 1 month . '!'he study was approved by the Ethical 
Committee on Human Studtes m the county of Aarhus. 
Lipid Extraction All solvents were ofhigh-pr~ssure liquid chro-
matographic (HPLC) gr~de (Rathburn, Pebblesh1re, UK) . The epi-
dermal specimen was qmckly we1ghed wh1le sull frozen and placed 
in an extraction tube containing 6 ml cold chlorofonn/methanol 
2: 1 (v jv), with .butyla~ed hydroxy toluene q3HT) (50 mg(l) as an 
antioxidant. Thmy micrograms of 23:0 (S1gma, St. Loms, MO) 
dissolved in chloroform was added as an internal standard for the 
quantification of FFA. This fatty acid was also present in the sam-
ples, but the error introduced was less than 10%. The sample was 
homogenized with an ~ltra Turrax (Janke & Ku~kel, FRG) at 
maximum speed for 1 mm. The sample was stirred on 1ce for 1 hand 
the pellet reextracted with 6 ml chloroform/methanol 2: 1 (v j v). 
The supernatants were joined and filtered (Whatman nr. 1). The 
filter and extraction tube were rinsed with 2 ml chloroform/meth-
anol. The solvent was evaporated at 40 •c under nitrogen and the 
lipid taken up in 0.5 ml chloroform. Separation of neutral lipids, 
FFA, and phospholipids was achieved on a solid phase of amino-
bonded silica (Bondesil, 40 J..l.m, Analytichem International, USA). 
The sorbent (0.5 g) was suspended in 10 ml heptane and poured 
into a small glass co lumn and allowed to settle. After washing with 
5 ml chloroform, the sample was applied. Neutral lipids were eluted 
with 12 ml chloroform and discarded. FFA were eluted with 8 ml 
of diethyl ether/acetic acid (93: 7 v /v), and finally, the phospho-
lipids were eluted with 8 ml methanol. Each collection vial con-
tained 5 JLg BHT. Purity of the fractions was examined by thin-
layer chromatograp?Y on plates ofSil.ica Gel60 (Merck, Darmstadt, 
FRG) in heptanejdtethyl ether/acetic aCid (70 : 20:4 v /v /v). The 
FFA fraction (approximately 300 J..l.g) was taken to dryness and fatty 
acid methylesters (FAME) were prepared with 0.5 ml boron tri-
fluoride in methanol (20%, Merck) [10] . The sample was heated at 
65 • C for 20 min. After cooling, 2 ml heptane was added, followed 
by 1 ml water; the mixture was then shake~. The heptane phase was 
aspirated and the solvent evaporated. Estenficat1on was c.omplete as 
judged by thin-layer chromatography. FAME were d1ssolved m 
125 j..l.l isooctane to a concentration of about 500 J..l.g/ml. 
The phospholipid fraction (approximately 5 mg) was taken to 
dryness and dissolved in 100 j..l.l chloroform/ methanol (2: 1 v /v) 
and ready for HPLC. 
HPLC Phospholipids were separated by normal-phase HPLC. 
The method of Andrews [11] was modified as follows. The pump 
(SP 8000) and integrator (SP 4270) were from Spectra-Physics and 
the detector (PU 4020) from Philips. The solvents were continually 
degassed with helium. The .following phospholipid s~andards were 
from Sigma: L-a-phosphaudylmoS!tol (PI) (ammomum salt, soy-
bean), L-a-phosphatidylethanolamine (PE) (egg yolk), L-a-phos-
pharidylserine (PS) (bovine brain) , and L-a-phospharidylcholine 
(PC) (egg yolk). The column material was silica (5 J.l.m, Sperisorb, 
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Figure 1. Typical HPLC chro':'atogram of epidermal phospholipids. Time 
in minutes is given on the x-ax1s, and the percentage of water m the eluent 
during the run is given on the right y-axis. PI , phosphatidylinositol; PS, 
phosphatidylserine; PE, phosphacidylethanolamine; PC, phosphatidylcho-
line; SPM, sphingomyelin. 
Mikrolab, Aarhus, Denmark) and the column dimensions 8 X 
250 mm I.D. The eluent was a gradient of acetonitrile/water, as 
shown in Fig 1. Absorbance was measured at 203 n~. PE.and PC 
from the epidermal samples were collecte? manually mto v1als con-
taining 5 j..l.g BHT in methanol. The fractiOns were taken to dryness 
on a rotary evaporator at 5o •c and fi~ally dried und~r a stream. of 
nitrogen at 4o•c. Purity of the fractions was exammed by thm-
layer chromatography on silica G gel with the solvent system chor-
oform/methanoljacetlc aCid/water 54:33:8.5:4.5 (v /v /v /v). 
FAME were prepared by transesterification with sodium methoxide 
[12]. For gas chromatografhy (GC), FAME were dissolved in isooc-
tane to a concentration o about 500 J.l.g/ml. 
Gas Chromatography The gas chromatograph used was model 
437 A (Chrompack, Delft, The Netherlands) equipped with an auto-
matic on-column sampler (Model 912, Chrompack). FAME 
(0.4 J..l.l) were injected onto a non-coated glass precolumn (0.5 m X 
0.32 mm) before separation on a 50-m X 0.25-mm capillary glass 
column coated with a 0.2 J..l.m film of CP SIL88 (Chrompack) . He-
lium was used as the carrier gas at a flow rate of2 mljmin. Injection 
was on column at 9o•c. The oven was programmed to rise to 
210 • C within 6 min and then run isothermally for 18 min. Integra-
tion was performed on a Shimadzu model C-3RA. FAME were 
identified by means of a standard mixture of known composition 
(Nu-Check, Elysian, MN). Healthy epidermis was processed in 
duplicate in order to determine the analytic variation in the fatty-
acid composition. The coefficient of variation for PC linoleic, diho-
mogamma-linolenic, and arachidonic acid in duplicate samples was 
3%, 4%, and 7%, respectively. 
Statistical Analysis All data are presented as mean± SD. Stu-
dent t test for paired data was used when comparing lesional and 
lesion-free epidermis, whereas the unpaired test was used when 
comparing atopic with healthy epidermis. All p values are two 
tailed. Regression and correlation analyses and analysis of variance 
(ANOVA) were performed with the statistical package "Statgra-
phics" (version 2.6, Statistical Graphics Corporation, Rockville, 
MD). 
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Table I. Relative Phosphoglyceride Content of Atopic and 
Heathy Epidermis•,b 
Atopic 
Lesional Lesion-free Healthy 
n = 14 11 = 14 n=9 
PE (mg/g) 1.8 ± 0.4 1.8 ± 0.4 1.0 ± 0.2' 
PC (mg/g) 10.0 ± 2.0 10.3 ± 1.7 5.4 ± 1.1 < 
• Values arc mean± SD and expressed as mg/g wet weight of tissue. 
! Relative to phospholipid standards from egg yolk. 
' Signifi cantly different from atopic epidermis by Student's t test for unpaired data 
(p < 0.001). 
RESULTS 
The recovery ofPE and PC standards during liquid- and solid-phase 
extraction was 90% (average of five determinations). The same 
recovery value was obtained for FFA. A representative HPLC chro-
matogram of epidermal phospholipids is shown in Fig 1. PE, PC, 
and sphingomyelin were the most abundant phospholipids in the 
epidermis. PS and PE were not baseline separated, but this was of 
minor concern, because the samples contained only small amounts 
ofPS. The collection ofPE was started with a slight delay, so as to be 
sure that no PS was collected. Linearity of the response curve for PE 
and PC standards was examined in the range of 0 .05 mg-2.5 mg. 
Because of fatty-acid differences between the standards and the epi-
dermal phospholipids, absolute quantitation was not possible by UV 
detection. The relative phospholipid content of atopic lesional, le-
sion-free, and healthy epidermis is given in Table I. Notable was the 
nearly twofold higher total content of phospholipids in both le-
sional and lesion-free atopic epidermis compared to the healthy 
epidermis. However, the ratio between PC and PE was identical in 
all three skin types. 
The fatty-acid composition of PE and PC in healthy and lesional 
and lesion-free atopic epidermis is given in Tables II and III. The 
fatty acids 14: 0 and 24: 0 were also present in the samples, but they 
could not be quantitated due to coelution with BHT and some 
unknown material. Trace amounts of 20: 3 n-3 and 22: 5 n-6 were 
present. No significant differences were found in the fatty-acid 
composition according to gender. Lesional epidermis differed signif-
icantly from lesion-free epidermis (p < 0.001) with regard to n-6 
fatty acids and MUFA in both PE and PC. Lesional epidermal PC 
contained only 49% of the arachidonic acid found in healthy epi-
dermis, whereas it was found to be 59% in lesion-free areas (Fig 2) . 
In contrast to this, the percentage of linoleic acid in both PE and PC 
from lesion-free epidermis was significantly higher than in healthy 
epidermis. Dihomogamma-linolenic acid in atopic epidermis was 
lower in PC but higher in PE, compared to healthy epidermis. 
Within the class of PC, strong inverse relationships were seen 
between oleic acid and linoleic acid, r = -0.77 in lesion-free and 
r =- 0.88 in lesional epidermis and r =- 0.64 in healthy epider-
mis; and between total n-6 and total MUFA, r = -0.88 in lesion-
free, r = -0.95 in lesional and r = -0.71 in healthy epidermis. 
Similar but weaker relationships were seen in PE. 
The relative composition of the FFA fraction of atopic epidermis 
is given in Table IV. The FFA data for healthy skin were not in-
cluded, because these samples were not frozen immediately in liquid 
nitrogen. This resulted in somewhat variable arachidonic acid le-
vels. The total FFA concentration of healthy epidermis (0.61 ± 
0.14 mg/ g wet weight of tissue) was still only half of that found in 
lesional (1.30 ± 0.74 mg/g) and lesion-free (1.23 ± 0.69) atopic 
epidermis. A significantly (p < 0.05) higher level of free arachi-
donic acid in lesional vs lesion-free epidermis was found, see Table 
V. The sum of the long-chain saturated fatty acids (LCSFA) 22:0, 
24:0, 25:0, and 26:0 was significantly (p < 0.01) reduced in le-
sional epidermis, whereas that of short-chain saturated fatty acids 
(SCSFA) had a tendency to be increased. 
The arbitrary disease severity index correlated inversely with the 
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Table II. Fatty Acid Composition of Phosphatidylethanolamine 
from Lesional and Lesion-Free Atopic Epidermis and from 
Healthy Epidermis• 
Atopic 
Lesional Lesion-free Healthy 
Fatty Acid 11 = 15 n = 14 n=9 
15:0 0.5 ± 0.3 0.6 ± 0.4 0.3 ± 0.2 
16:0 8.5 ± 1.5 7.7 ± 1.7 8.9 ± 2.7 
16: 1h 3.3 ± 1.0 2.9 ± 1.7 2.3 ± 1.3 
17:0 1.3 ± 0.5 1.2 ± 0.3 1.3 ± 0.4 
17: 1 b 0.7 ± 0.4 0.6 ± 0.1 0.5 ± 0.3 
18:0 12.7 ± 1.9< 11.0 ± 1.0 11.6 ± 1.0 
18: 1b 21.1 ± 2.9< 19.0 ± 2.4 15.4±1.0 
18:2 n-6b 21.1 ± 3.0' 24.8 ± 2.9 22.3 ± 2.4 
20:0 0.3 ± 0.1 0.2 ± 0.1 0.3 ± 0.1 
18:3 n-6 0.1 ± 0.09• 0.2 ± 0.2 0.1 ± 0.06 
20: 1 n-11 0.5 ± 0.1' 0.4 ± 0.1 0.3 ± 0.09 
18:3 n-3 0.3 ± 0.1 0.3 ± 0.09 0.2 ± 0.1 
20: 1 n-9 0.2 ± 0.07 0.2 ± 0.07 0.2 ± 0.06 
20:2 n-6 0.4 ± 0.1 0.3 ± 0.1 0.2 ± 0.07 
22:0 0.1±0.1 0.1 ± 0.2 0.2 ± 0.1 
20:3 n-6 2.2 ± 0.7 2.3 ± 0.8 1.8 ± 0.4 
22: 1 n-9 0.2 ± 0.3 0.2 ± 0.3 0.1±0.1 
20:4n-6 16.8 ± 2.9' 18.8 ± 3.2 23.1 ± 2.5 
20:5 n-3 1.1 ± 0.4< 1.0 ± 0.4 0.7 ± 0.2 
22:4 n-6 1.1 ± 0.3 1.2 ± 0.3 1.8 ± 0.4 
22:5 n-3 1.6 ± 0.5 1.6 ± 0.4 1.7 ± 0.2 
22 :6 n-3 5.5 ± 1.2 5.4 ± 1.1 6.4 ± 0.7 
SFN 23.4 ± 2.8' 20.8 ± 2. 1 22.6 ± 3.0 
MUFAR 26.0 ± 2.8' 23.3 ± 2.1 18.7 ± 1.7 
PUFN• 49.5 ± 3.6' 54.8 ± 3.2 57.0 ± 3.3 
n-6; 42.1 ± 3.1' 47.7 ± 3.1 49.6 ± 3.4 
n-3.i 8.5 ± 1.9 8.2 ± 1.8 9.1 ± 0.8 
• Values arc mean'!= SO and expressed as o/o by weight of total fatty acids. Signifi-
c:mcc levels arc of difference between les10nal and lesion-free skin by Student t test for 
paired data . 
b Includes various isomers. 
'p < 0.05. 
'p < 0.01. 
'p < 0.001 
f saturated fatty acids. 
x monounsacuratcd fatty acids. 
h polyunsaturated fatty acids. 
; n-6 fatty acids. 
j n-3 fatty acids. 
linoleic acid content (r = -0.74, p < 0.01) and directly with the 
ole1c aCJd content (r = 0.79, p < 0.001) of lesion-free epidermal 
PC. When total n-6 and MUFA were considered, the correlations 
became even stronger (Fig 3). The same, but weaker, associations 
were found for lesional epidermis. Furthermore, by AN OVA we 
found that both itch and dryness of the lesion-free skin were signifi-
cantly and positive.ly associated with the lesion-free epidermal PC 
content of ole1c aCid and total MUFA (Fig 4) . 
DISCUSSION 
Data on the fatty-acid composition of phosphoglycerides from 
human epid~rmis. are s~arce. We compared the fatty-acid composi-
tJon of atopic epidermis taken mainly from the extremities, with 
epidermis obtained from healthy subjects undergoing plastic sur-
gery of the breast. A potential problem is that of site specificities in 
epidermal phospholipid fatty-acid composition. We do not think. 
this is critical however, because patient samples, which were taken 
from various locations, were relatively homogenous with regard to 
the phosphoglyceride content. Also, due to hyperkeratinization of 
the atopic epidermis, one could expect to obtain less of the lower 
cellular epidermis, which is the primary location of phospholipids 
in keratome biopsies from patients, compared to healthy subjects. 
Because we found a higher phospholipid content in atopic epider~ 
mis, we do not think that the difference between patients and con-
trols was due to sampling technique. 
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Table III. Fatty-Acid Composition of Phosphatidylcholine 
from Lesional aqd Lesion-Free Atopic Epidermis and from 
H ealthy Epidermis• 
Atopic 
Lcsional Lesion-free Healthy 
Fatty Acid n = 15 11 = 15 n=9 
15:0 2.0 ± 0.5• 1.7 ± 0.5 1.1 ± 0.2 
16:0 22.7 ± 1.4d 21.5 ± 1.5 23.6 ± 1.3 
16: 1b 4.6 ± 1.3• 3.3 ± 1.0 2.4 ± 0.3 
17:0 1.4 ± 0.3 1.5 ± 0.3 1.5 ± 0.5 
17 : 1 b 1.1 ± 0.3d 0.8 ± 0.3 0.5 ± 0.1 
18:0 9.0 ± 1.3• 10.4 ± 1.2 12.3 ± 0.9 
18: 1 b 23.7 ± 2.9d 21.8 ± 2.0 18.7 ± 0.9 
18:2 n-6b 27.2 ± 3.9d 30.2 ± 3.2 27.0 ± 2.5 
20:0 0.3 ± 0.2' 0.3 ± 0.2 0.4 ± 0.07 
18 : 3 n-6 0.2 ± 0.07 0.2 ± 0.09 0.2 ± 0.1 
20 : 1 n-11 0.4 ± 0.07d 0.4 ± 0.06 0.3 ± 0.03 
18:3 n-3 0.2 ± 0.1 0.2 ± 0.07 0.1 ± 0.02 
20 : 1 n-9 0.2 ± 0.05 0.2 ± 0.06 0.2 ± 0.04 
20:2 n-6 0.5 ± 0.09 0.5 ± 0.1 0.4 ± 0.05 
22:0 0.3 ± 0.3' 0.3 ± 0.2 0.2 ± 0.1 
20:3 n-6 1.1 ± 0.3d 1.3 ± 0.4 1.5 ± 0.2 
22 : 1 n-9 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.04 
20:4 n-6 3.6 ± 1.0' 4.3 ± 1.2 7.3 ± 1.2 
20:5 n-3 0.2 ± 0.08 0.2 ± 0.08 0.2 ± 0.07 
22 : 4 n-6 0.2 ± 0.07 0.2 ± 0.05 0.3 ± 0.06 
22: 5 n-3 0.2 ± 0.09 0.2 ± 0.07 0.4 ± 0. 2 
22:6 n-3 0.6 ± 0.1 0.5 ± 0.2 1.0 ± 0.2 
SFAf 35.7 ± 1.1 35.6 ± 1.4 39.2 ± 1.5 
MUFAs 30.4 ± 3.9' 26.8 ± 2.7 22.4 ± 1.1 
PUFA" 33.8 ± 3.8' 37.5 ± 2.9 38. 1 ± 2.0 
n-6; 32.8 ± 3.8' 36.5 ± 3.1 36.8 ± 2.1 
n-3 i 1.2 ± 0.3 1.1 ± 0.3 1.7 ± 0.3 
• Values arc mean ± SO and expressed JS % by weight of total fa try acids. Signifi-
cance levels arc of difference between lcsional and lesion-free skin by Student t test for 
pai red data. 
b Includes various isomers. 
'p < 0.05. 
J p < 0.01. 
'p < 0.001. 
I satura ted fatty acids. 
11. monounsaturated fatty acids. 
• polyunsaturated faery acids. 
; n-6 faery acids. 
J n-3 fatty acids. 
The leve ls of PE and PC (which account for 60% of tota l phos-
pholipids in the epidermis (13]) reported by us (6.5 mg/g wet tissue) 
seem appropriate when it is assumed that the total lipid content of 
th e epidermis is 5% for the abdomen and leg [14] and that total 
phospholipids account for approximately 20% [15] of total lipids in 
our samples, which consisted of the upper t of the epidermis. 
The relative composition of the FFA fraction found in the present 
srud y is in good agreement with th e results of Nicoll ier, Massengo, 
Remy-Matin et a! [16], who analyzed it in -patients with various 
forms of palmoplantar keratoderma. These authors observed an ele-
vated level ofSCSFA and a decreased level ofLCSFA in the stratum 
corneum of these patients compared to healthy subjects, and 
ascribed this to a defect in the maturation of fatty acids. We ob-
served th e same difference in the FFA pattern when comparing 
lesional with lesion-free epidermis from our AD patients, indicating 
th at a shift from LCSFA to SCSFA is a general feature of the hyper-
keratotic epidermis. Hydroxylated long-chain saturated and mono-
unsaturated fatty acids (C28-C34) are components of acylceramides 
[17]. A defective maturation of fatty acids could therefore lead to an 
impaired acylceramide synthesis. 
The reason for the elevated phospholipid content in both lesional 
and lesion-free epidermis of AD patients compared to healthy sub-
jects could be epidermal hyperplasia, a known phenomenon in AD 
skin (3], or an incomplete phospholipid degradation . Elevated phos-
pho lipid levels have abo been found in involved psoriatic epidermis, 
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Figure 2. N-6 fatty acids in phosphoglycerides. Comparison between the 
relative content (percent by weight) in phosphatidylethanolamine (PE) and 
phosphatidylcholine (PC) in les ional and lesion-free atopic epidermis and 
healthy epidermis. Asterisks indicate sign ifica nce level of difference com-
pared to healthy skin; *p < 0.05 , **p < 0.01, •••p < 0.001. 
but not in the uninvolved epidermis (13] . D uring normal epidermal 
cell differentiation, phospholipids are degraded, w hereas the synthe-
sis of acylceramides is initiated [1] . Several lines of evidence indicate 
that the process of lipid translocation and transformation is dis-
turbed in the epidermis of AD patients. First, Werner, Lindberg, 
and Forslind (18], in studying the membrane-coating granul es 
(which carry the lipids destined for extrusion into th e stratum cor-
neum) in AD patients by electronmicroscopy, found that matura-
tion of epidermal granules and/or their lipid synthesis was dis-
turbed. Second, Melnik, Hollmann, and Plewig (19] have reported 
that the content of ceramides was depressed in the stratum corneum 
of AD patients. An impaired biosynthesis of ceramides and/or a 
defective acylation of ceramides could explain the increased transep-
idermal water loss of the atopic epidermis. In essential fatty-acid 
deficiency, linoleate is replaced by oleate in th e acylceramides. T his 
alters the physical properties of these molecu les, which cannot as-
semble into a proper lipid sheet [1]. 
Another prominent findi:-~g was the strong inverse association 
between disease severity and th e n-6 fatty acid content ofl esion-free 
Table IV. Relative Composition of th e Free Fatty-Acid Fraction 
of Lesional and Lesion-Free Atopic Epidermis• 
Lcsional Lesion-Free 
Fatty Acid n = 15 11 = 14 
14 :0 3.0 2.5 
14: 1 2.8 2.1 
15 :0 1.9 1.2 
15: 1 1.2 2.1 
16 :0 20.8 18.5 
16: 1 4.5 6.3 
17 :0 1.6 1.5 
17: 1 2.9 2.5 
18:0 17.2 16.4 
18 : 1 14.0 9.0 
18 :2 9.4 10.0 
20:0 1.8 2.0 
20: 1 0.7 0.8 
22:0 3.3 4.1 
20 :4 0.5 0.4 
24:0 7.1 10.5 
25:0 1.1 2.1 
26: 0 2.5 4.5 
'Values arc mea ns and expressed as percent by weight of tota l FFA. Farry acids 
constituting < 0.4% arc not shown. 
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Table V. Free Fatty Acids in Lesional and Lesion-Free Atopic 
Epidermis• 
AA (J.imol/g)b 
LCSFA (Jlmol/g)' 
SCSFA (Jlmol/g)J 
Lesional 
n = 15 
21.7 ± 15.0' 
497 ± 278! 
2189 ± 1032 
Lesion-free 
n = 14 
14.8 ± 9.5 
700±310 
1849 ± 1167 
• Values arc mean± SD, and expressed as ;onol/g wee weight of tissue. 
I Arachidonic acid. 
'Long-chain saturated fatty acids, 22:0 + 24:0 + 25:0 + 26:0. 
'Short-chain saturated f.my acids, 14:0+ 15:0+ 16:0+ 17:0+ 18:0. 
'Significance level of difference, p < 0.05. 
f Significance level of difference , p < 0.01. 
atopic epidermis and the elevated concentration o~ free arachid~nic 
acid in lesional compared to leswn-free ep1denm s. Both fin~mgs 
suggest that th e activity of phospholipase A2 is increased in leswnal 
atop ic epidermis, possibly as acon~equence of cutaneous mflamma-
tion. Increased free arach1domc ae1d levels have been found m psor-
iat ic epidermis by Hammarstro m, Hamberg, Samuelsson et ~I (20], 
where t he reported concentrations were 1.4 Ji.g/g wet. weight of 
tissue in les ion-free and 36.3 JJ.g/g in leswna l epider.mJs. Later, It 
was shown .that P.hosp holir.ase A2 activity is elevated m l es 1~n-free 
psoriatiC ep1denms, also [8 . When expressed tn J1.g/ g wet we1ght of 
tissue, our values were 2.9 Jlg/g and 4.6 Jlg/g for lesw.n-free a~d 
lesional atopic epidermis, respectively. The sum of aracludomc ac1d 
metaboli tes PGE2, L TB4 , 12-hydroxy-e1cosatetraeno1c aod and 1 5-hydroxy-e i cosatetrae~oic a~ i d reported previously ~or atopi.c le-
sion-free and leswnal epidermis was 0.2 Jlg/g w~t we1ght of t1ssue 
and 1.5 Jlg/g, respect ively [5]. A rough c:aiculat i~n .shows that 111 
les ion-free epidermis, 7% of the free arach1dom~ ae1d. IS oxy~enated, 
w hereas in lesio nal epidermis this percentage IS 4 wnes h1gher. A 
study by Ziboh and Lord [7] has show n tha~ the ~ctivit~ of phospho-
li pase A2 can be stimulated by PGE2 and h1stammm v1tro, su.gges~­
in g a positive feedback-reg~latm~ mech~msm of the aracludomc 
acid inflammatory cascade 111 leswna l ep1denms. A furt~er argu-
ment for an increased activity of phospho lipase A2 m atop1c eczema 
is the positive clinical effect of anti- inflammatory s ~eroids , which, 
among other effects, inhibit th e act ivity of phospholtpase A2[21 ]. ~ 
direct measurement of enzyme actiVIty 111 the atop1c epidermis 
should be performed in order to settle this question. . . . 
Our results suggest that there is a defective maturatiOn of hp1ds , 
and fatty acids in the atopic epidermi~. Thi? ~ou ld lead to a.defec-
tive structure of the intercellul ar mult!ple-hp1d b1layer const1tutmg 
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Figure 3. Disease severity index and epidermal fatty acids. Relative content 
(% by weight) of n-6 fatty acids (solid circles) and monounsaturated fatty ac1ds 
(opm circles) in phosphatidylcholine from lesion-free atop1c ep1dernm. 
Crosses indicate means and 95% confidence mtervals of values found 111 
phospbatidylcholine from healthy epidermis. 
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Figure 4. Itch (solid circles) and dryness (opm circles) of lesion-free atop.ic 
skin and epidermal fatty ac ids. Monounsaturated fatty ac ids(% by weight) 111 
lesion-free epidermal phosphatidylcholine are given on the y-ax is. Bars, 
95% confidence intervals for factor means; p = 0.01 for dryness, and p == 
0.006 for itch by ANOV A. 
the water barrier in the stratum corneum, and subsequently to an 
increased evaporative water loss and dry ski n. A decreased barrier 
function could also explain t he inadequate skin barrier against irn-
tants, toxins, and infectious agents seen in AD patients [22]. The 
development of a skin lesion could be envisioned to take place at a 
particularly permeable site on the skin. Allergens and infectious 
agen ts could penetrate the barrier and evoke cutaneous inflamma-
tion, resulting in an increased. phospholipase A2 activ ity and release 
of PUFA. These would then become substrates for lipoxygenases 
and cyclooxygenase, sy nth esizing infl ammatory mediators like 
PGE2, L TB4 , and hydroxy fatty acids, and leading to a further 
stim ulation of phospholipase A2 act ivi ty. This would contribute to 
th e feeling of itch and, subsequently, even visible lesions would be 
produced on the skin. Further studies shoul d be devoted to th e area 
of lipid and fa tty acid metabolism of th e atopic epidermis, and in 
particular, acylceramide synthesis should be further investigated. 
The technical assistance of Berit Kristensen is gratejit!ly acknorvledged. 
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ANNOUNCEMENT 
In 1991, the Certifying Exa mination of the American Board of Dermato logy will be held at the 
Holiday Inn O'Hare Airport in Rosemont, Illinois on November 3 and 4, 1991. The dead line 
for receipt of applications is May 1, 1991. 
The Dermatopathology Special Qua li fication Examination wi ll be held in Rosemont, Illi-
nois on November 1, 1991. The dead line for receipt of applications is July 1, 1991. 
The Examination for Special Qua li ficat ion in Dermatological Immunology /Diagnostic and 
Laboratory Immunology wi ll be held in Rosemont, Illinois on November 1, 1991. The dead-
line for receipt of applications is Apri l 1, 1991. 
For further information on th ese examinations, please contact Clarence S. Livingood, M .D., 
Executive Director, American Board of Dermato logy, Henry Ford Hospital , Detroit, Ml 
48202. 
